Creative Studio Powster Announces Innovation for Movie Studios
Movie studios can now sell movie theater tickets on their official movie websites. Cinemagoers can now buy tickets directly on websites such as www.deadpool.com, www.adrift.movie, www.equalizer.movie, and the upcoming site for Mission: Impossible - Fallout. These ticketing portals are activated across all social media, meaning studios can now sell their own tickets from their Facebook, Twitter, Instagram and other social media channels.
Powster creates movie websites for all six major studios and launches over 170 sites every month. After successful Beta testing, Powster has now enabled full ticketing on these movie websites so that cinemagoers can complete the entire purchasing journey without redirecting the user to a third-party website.
Powster’s ability to launch full-ticketing at scale is in part related to movieXchange’s MX Tickets service, Vista Group’s new global ticketing platform allowing ticket sellers to integrate with and transact against all exhibitors. By integrating the full payment process into the movie site, Powster has improved the user journey of purchasing a ticket letting users purchase directly on the movie website, making going to the cinema easier than ever.
The Powster ticketing model is unique to the industry. Payments are deposited directly with the theater, eliminating the administrative hang-ups previously associated with third-party ticket sales. For studios, Powster ticketing ensures visibility and measurement of the entire purchasing process culminating in actual ticket sales.
Hollywood distributors and industry partners Twentieth Century Fox Film, Paramount Pictures, STXfilms, RealD, Annapurna, The Orchard, CBS Films, Magnolia Pictures, Amazon Studios, ShortsTV, FilmRise, GKIDS, Gunpowder & Sky, and more have partnered with Powster and integrated full ticketing flow into their systems.
Powster CEO Ste Thompson says, “We have researched into the best solution for both movie theaters and movie distributors. Our solution equally benefits both parties by enabling the movie studio to optimise their advertising and the movie theater to retain the customer.”
Over 20 theaters have signed on to implement Full Ticketing upon its release. B+B Theatres, New Vision Cinemas, Celebration Theatres, Starlight Cinemas, Paramount 5, D’Place Entertainment, Envision Cinemas Bar & Grille, Main Street Theatres, Midwest Movies, FatCats Entertainment, and Tristone Cinemas are early adopters of the new system. Full Ticketing will reach over 27,000 screens in its first month(s) of processing.
Powster ticketing can be integrated into social platforms, such as Facebook, Snapchat, and Instagram, so users can complete their ticket purchase without leaving the site. Full ticketing has also been built into Powster’s Facebook Messenger experiences, where users can set reminders, watch movie trailers, and organize showtimes with friends all without leaving Messenger.
Powster will be exhibiting Full Ticketing, AR capabilities, and Messenger integration at CineEurope, in the main foyer, across from the trade show registration booth. If you would like to arrange a chat in advance, please email PR and Marketing Coordinator Samantha Robinson - email@example.com.
POWSTER, part of the Vista Group of companies (NZX: VGL) (ASX: VGL), is a creative and innovation studio operating in London and Los Angeles. The business provides creative services to the film and music industry and creates products to help engage users with entertainment content. The global leader in film distribution marketing websites, POWSTER creates more than 170 destinations a month for 100+ movie distributors in over 40 countries. The POWSTER movie platform enables over thirty-five million cinemagoers a month to discover showtimes on official movie websites.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)22.9.2018 01:13 | Tiedote
Glorious beaches by day and theme park fireworks by night just got more convenient for Philadelphia travelers. American Airlines announced today that it will begin nonstop flights to Orlando Melbourne International Airport (MLB) starting February 16, 2019. The Central Florida airport is conveniently located in the heart of the tourism region and is the closest airport to NASA rocket launches, Port Canaveral’s cruises and what critics call “some of the most beautiful beaches Florida has to offer.” The flights will depart Saturdays from Philadelphia at 8:05 a.m., arriving in Florida at 10:48 a.m. The Embraer 175 jet arrival time syncs perfectly with cruise ship noon early boarding. Melbourne Airport Express offers nonstop shuttle service to the port, and all major rental car companies are onsite. The return flight to PHL departs at 11:24 a.m. and arrives in PHL at 1:55 p.m., with enough time to connect to some of American’s largest international destinations, including recently announced
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice21.9.2018 20:43 | Tiedote
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Amy Palladino has joined the agency as Executive Vice President, Managing Director in the agency’s U.S. Corporate Practice. Based in New York, Palladino will focus on senior client counsel and executive positioning for the agency’s largest corporate clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005507/en/ Amy Palladino Joins BCW (Burson Cohn & Wolfe) “Amy is a talented and highly experienced communications executive with a track record of solving clients’ complex challenges and building business through smart, integrated communications approaches,” said Chris Foster, President, North America, BCW. “Her creativity and judgement will be enormously valuable to our current and prospective clients.” Palladino has more than 20 years of experience advising global clients across numerous industries, including technology, healthcar
Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 19:41 | Tiedote
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo
Florian Winterstein Becomes New CEO of Jedox21.9.2018 18:46 | Tiedote
The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter21.9.2018 17:37 | Tiedote
Since 2010 Avinor has had a vision and a desire to automate winter maintenance. In March autonomous snow clearing was demonstrated at Fagernes Airport, and this winter Avinor is taking this a step further by testing two autonomous snowploughs at Oslo Airport. The project is one of the first globally where large machinery will operate autonomously to keep snow away from airport areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005363/en/ Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter (Photo: Business Wire) “Innovation is important to Avinor. In the future, many tasks in aviation will be resolved in other ways than today. Avinor wants to test autonomy, and does of course see a potential for rationalization in the future through new solutions for winter operations and in other areas. Avinor is at the forefront of testing this technology, but it is essential that safety is ensured in all such testing
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 16:30 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme